In 2016, B&C® Consortia Management, L.L.C. (BCCM) will be leveraging its considerable resources on a wide range of advocacy, regulatory, science policy, testing, and communication activities for BCCM consortia members. BCCM is authorized to operate in the U.S. and Europe. We identify in our Spring 2016 Outlook specific initiatives, including group formation invited by regulatory actions, focused on needed policy changes or desires to improve worker safety.
The reasons for forming and maintaining a coalition are varied. There is great truth to the proverb, 'Many hands make light work.' As companies and related stakeholders consider the regulatory, policy, and stewardship challenges facing them today, they would be well-served to consider if it makes sense to tackle those challenges under a consortium umbrella. The likelihood is that an individual entity is not always well-suited to complete a costly testing program, influence policy change, or raise industry standards, but entities working together with a unified voice are.
We invite stakeholders to consider whether they too should engage in any existing BCCM consortia, or to identify other testing or advocacy areas where forming a consortia makes sense.
Our 2016 Spring Outlook on regulatory, testing, and policy triggers for chemical consortia includes sections on:
- EPA Endocrine Disruptor Screening Program
- TSCA Work Plan Chemicals
- FIFRA Activities
- IRIS Reviews
- Policy Changes
- Product Stewardship